PMS-PAZOPANIB

Pharmascience Inc🇨🇦 Health Canada

Approval Id: fa56871bd3d8c840
Drug Approval Canada Name: PMS-PAZOPANIB
Product Name: PMS-PAZOPANIB
Status: Marketed
Status Date: 2022-08-31
Original Market Date: 2022-08-31
Din: 02525666
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EX03 PAZOPANIB
Atc Name: l 01 ex 03
Aig Number: 0152743001
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

PAZOPANIB (PAZOPANIB HYDROCHLORIDE)

200 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fa56871bd3d8c840

Type

Standard